Abrax Japan (Tokyo, Japan) has established a wholly owned subsidiary company in Australia.
Abrax Japan intends to carry out both the pre-clinical and clinical trials through the new entity in Australia. Australia offers a wide range of patient population and, with their advancement in technology, Abrax seeks to gain valuable data from the various clinical trials it intends to carry out.
Abrax Australia PTY LTD was established on July 13, 2021 in Victoria, Australia. Directors of the company are Mr. Jo Narita and Dr. Tom Burn.